STOCK TITAN

Perceptive Advisors reports 7.7% RACD stake in Research Alliance Corporation IV (RACD)

(Neutral)
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Research Alliance Corporation IV received a Schedule 13G reporting that Perceptive Advisors LLC, Joseph Edelman and Perceptive Life Sciences Master Fund, Ltd. collectively beneficially own 700,000 Class A Ordinary Shares. This represents 7.7% of the 9,098,529 Ordinary Shares outstanding as of July 13, 2026.

The Master Fund directly holds the 700,000 shares. Perceptive Advisors, as investment manager, and Mr. Edelman, as managing member, may be deemed to beneficially own these shares. All three reporting persons have shared voting and dispositive power over 700,000 shares and no sole voting or dispositive power.

Positive

  • None.

Negative

  • None.
Beneficially owned shares 700,000 Class A Ordinary Shares Held by Perceptive Life Sciences Master Fund, Ltd. as reported by the group
Ownership percentage 7.7% Percent of Class A Ordinary Shares beneficially owned by each reporting person
Shares outstanding 9,098,529 Ordinary Shares Outstanding Class A Ordinary Shares as of prospectus dated July 13, 2026
Shared voting power 700,000 shares Shared voting power reported by each of the three reporting persons
Shared dispositive power 700,000 shares Shared power to dispose reported by each of the three reporting persons
beneficially own financial
"may be deemed to beneficially own shares held by the Master Fund"
Beneficially own means having the economic rights and risks of a security—such as the right to receive dividends, sell the shares, or profit from price changes—whether or not your name appears on the official share register. Think of it like renting a car: you use it and reap the benefits even if the title lists someone else. Investors care because beneficial ownership determines who truly controls value, must be disclosed under securities rules, and can signal potential influence or trading activity that affects a stock’s price.
Schedule 13G regulatory
"The ownership percentages are based on 9,098,529 Ordinary Shares outstanding"
A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.
shared voting power financial
"Shared Voting Power 700,000.00"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
shared dispositive power financial
"Shared Dispositive Power 700,000.00"
CUSIP Number regulatory
"CUSIP Number(s): G75228109"
A CUSIP number is a nine-character code that uniquely identifies a specific U.S. or Canadian stock, bond, or other security, similar to a barcode or a social-security number for a financial instrument. It matters to investors because it removes confusion between similar securities, ensures trades and settlements are applied to the correct issue, and helps locate official documents and transaction records quickly.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What ownership stake in RACD did Perceptive Advisors report on Schedule 13G?

Perceptive Advisors and related reporting persons disclosed beneficial ownership of 700,000 Class A Ordinary Shares of RACD. This position represents 7.7% of the 9,098,529 Ordinary Shares outstanding as of July 13, 2026.

How many Research Alliance Corporation IV shares are outstanding (RACD)?

The Schedule 13G states that there are 9,098,529 Class A Ordinary Shares outstanding of Research Alliance Corporation IV. The 7.7% stake reported by the Perceptive entities is calculated based on this outstanding share count.

Who are the reporting persons on the RACD Schedule 13G?

The reporting persons are Perceptive Advisors LLC, Joseph Edelman, and Perceptive Life Sciences Master Fund, Ltd.. The Master Fund directly holds the shares; Perceptive Advisors and Mr. Edelman may be deemed to beneficially own them through their roles.

How many RACD shares does Perceptive Life Sciences Master Fund directly hold?

Perceptive Life Sciences Master Fund, Ltd. directly holds 700,000 Class A Ordinary Shares of RACD. This direct holding underlies the 7.7% beneficial ownership position reported jointly with Perceptive Advisors LLC and Joseph Edelman.

What voting power do the Perceptive entities have over RACD shares?

Perceptive Advisors, Joseph Edelman and the Master Fund report shared voting power over 700,000 shares and no sole voting power. They also report shared dispositive power over the same 700,000 shares and no sole dispositive power.

What class of RACD securities is covered by this Schedule 13G?

The Schedule 13G covers Class A Ordinary Shares, par value $0.0001 per share, of Research Alliance Corporation IV. The reported 7.7% beneficial ownership and all voting and dispositive power figures relate specifically to this class.





G75228109

(CUSIP Number)
07/13/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Perceptive Advisors LLC
Signature:/s/ Joseph Edelman
Name/Title:Joseph Edelman, Managing Member
Date:07/20/2026
Joseph Edelman
Signature:/s/ Joseph Edelman
Name/Title:Joseph Edelman
Date:07/20/2026
Perceptive Life Sciences Master Fund, Ltd.
Signature:/s/ Joseph Edelman
Name/Title:Joseph Edelman, Managing Member
Date:07/20/2026
Exhibit Information

Exhibit 99.1 - Joint Filing Agreement